Score range | Baseline | 6 months | 12 months | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Experimental mean (SD) | Control mean (SD) | Group diff | Experimental mean (SD) | Control mean (SD) | Group diff | Experimental mean (SD) | Control mean (SD) | Group diff | ||
1 – Eligibility of clients | 0-8 | 5,65 (1,12) | 5,92 (1,08) | −0,36 | 5,75 (1,21) | 5,48 (1,33) | 0,27 | 5,82 (1,43) | 5,67 (1,33) | 0,15 |
2 - Effect on client | 0-9 | 4,35 (2,09) | 4,52 (1,78) | −0,17 | 4,21 (2,04) | 5,00 (1,29) | −0,79 | 4,65 (1,80) | 4,96 (1,63) | −0,31 |
3 – Effect on caregiver | 0-9 | 4,24 (1,95) | 5,28 (2,05) | −1,04 | 4,50 (2,06) | 5,48 (1,16) | 0,98 | 5,18 (1,47) | 5,56 (1,16) | −0,38 |
4 - General content | 0-4 | 2,53 (0,87) | 3,08 (0,86) | −0,55 | 0,0 (0,0) | 0,0 (0,0) | 0 | 3,18 (0,39) | 2,89 (1,22) | 0,29 |
5 - Pharmacological vs. non-pharmacological | 0-4 | 2,24 (1,09) | 2,00 (1,12) | 0,24 | 1,89 (1,10) | 2,12 (1,20) | −0,23 | 1,47 (1,07) | 1,59 (0,84) | −0,12 |
6 – Facilitation | 0-3 | 2,06 (0,90) | 2,36 (0,70) | −0,3 | 1,86 (0,89) | 1,96 (0,84) | −0,1 | 1,88 (0,93) | 2,19 (0,96) | −0,31 |
7 – Cost-effect | 0-3 | 0,0 (0,0) | 0,04 (0,20) | −0,04 | 0,14 (0,36) | 0,04 (0,20) | 0,1 | 0,06 (0,24) | 0,11 (0,32) | −0,05 |
8 – Reimbursement | 0-5 | 3,88 (1,45) | 3,54 (1,33) | 0,34 | 4,39 (0,96) | 3,08 (1,75) | 1,31 | 4,12 (1,65) | 3,63 (1,64) | 0,49 |